logo
Fibrinogen gene variation and ischemic stroke
Ante- and postnatal risk factors of venous thrombosis
Microparticle-mediated thrombin generation assay
P-selectin polymorphisms' influences on P-selectin serum concentrations and on their familial correlation
Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage
A first-in-human phase I trial of locally delivered human plasmin for hemodialysis graft occlusion
Cytoprotective effect of activated protein C
Lipid raft localization regulates the cleavage specificity of protease activated receptor 1 in endothelial cells
Comparison of the capacities of two prothrombin complex concentrates to restore thrombin generation in plasma from orally anticoagulated patients
Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice
Quercetin induced tissue-type plasminogen activator expression is mediated through Sp1 and p38 mitogen-activated protein kinase in human endothelial cells
Tissue factor and IL8 production by P-selectin-dependent platelet–monocyte aggregates in whole blood involves phosphorylation of Lyn and is inhibited by IL10
Protein C supports platelet binding and activation under flow
Ex vivo inhibition of thrombus formation by an anti-glycoprotein VI Fab fragment in non-human primates without modification of glycoprotein VI expression
Globular adiponectin induces platelet activation through the collagen receptor GPVI-Fc receptor γ chain complex
Circulating endothelial cells in health and disease
Quantitative detection of circulating endothelial cells in vasculitis
Non-invasive viral gene transfer of factor IX to colonic epithelial cells in hemophilia B mice
The Src requirement for washed platelet aggregation and dense granule secretion in response to stimulation by a low level γ-thrombin
Application of a pharmacogenetic-based warfarin dosing algorithm derived from British patients to predict dose in Swedish patients
The importance of anticoagulant agents in measuring platelet aggregation in patients treated with clopidogrel and aspirin
Continuation of the international standard thromboplastin (human, recombinant, plain) by means of a replacement reconstitution fluid
Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa–tissue factor
Protease activated receptor 1 activation of platelet is associated with an increase in protein kinase CK2 activity
A contribution to the debate on the laboratory criteria that define the antiphospholipid syndrome
More on
Acquired von Willebrand disease
Lower factor XII activity is a risk marker rather than a risk factor for cardiovascular disease
Coagulation factor XII activity, activated factor XII, distribution of factor XII C46T gene polymorphism and coronary risk
Join ISTH